August 6, 2025 - 23:19

Tenaya Therapeutics has announced significant progress in its clinical trials, marking a pivotal moment for its innovative therapies targeting specific heart conditions. The enrollment process for Cohorts 1 and 2 of the MyPEAK™-1 Phase 1b/2 trial of TN-201, aimed at treating MYBPC3-associated hypertrophic cardiomyopathy (HCM), has been successfully completed. This achievement has been bolstered by a positive safety review from the Data Safety Monitoring Board (DSMB), which has now allowed the company to proceed with the enrollment of expansion cohorts.
In addition, the RIDGE™-1 Phase 1b trial of TN-401 has also made strides, with Cohort 1 fully enrolled and the first patient with PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC) dosed in Cohort 2. This advancement follows the DSMB's recommendation to escalate dosing and expand the trial.
Tenaya Therapeutics is set to provide data readouts from both clinical programs in the fourth quarter of 2025, with a cash runway projected to extend into the second half of 2026, ensuring continued development of these promising therapies.
November 19, 2026 - 10:57
Goldman Sachs Invests $280 Million in Payhawk's Finance Operating SystemGoldman Sachs has taken a significant step in the fintech arena by leading a funding round of $280 million for Payhawk. This investment aims to enhance Payhawk`s global Finance Operating System,...
November 18, 2026 - 20:28
Urgent Need for Social Security Reform as Financial Issues EscalateDecades of political gridlock over entitlement reforms are coming to a head as Congress confronts a dwindling opportunity to avert significant cuts to Social Security benefits. The program, which...
November 18, 2026 - 01:16
Austin Peay State University to Present Documentary "This Is Not Financial Advice"Austin Peay State University will host a screening of the documentary `This Is Not Financial Advice` on December 1. This film delves into the complexities of financial literacy and the often murky...
November 17, 2026 - 03:36
Sarah Wetmore Takes the Helm as Executive Director of the Center for Municipal FinanceIn a significant move for the Center for Municipal Finance, the University of Chicago Harris School of Public Policy has appointed Sarah Wetmore as its new Executive Director. Wetmore brings a...